An unconditional approval of Life Healthcare and Joint Medical Holdings has been granted by the Competition Tribunal for the companies who own private South African hospitals. The Competition Commission had previously asked the Tribunal to prohibit the merger, citing competition concerns. The Tribunal’s biggest concern, according to reports, was in regards to whether Joint Medical Holdings’ pricing of medical schemes would increase after the merger, but ultimately found the deal does not pose a threat to competition.
Featured News
Apple Opens Early Settlement Discussions With DOJ
Jul 17, 2026 by
CPI
South Korean Steelmaker POSCO Expands Supplier Support Pact With Antitrust Regulator
Jul 16, 2026 by
CPI
FCC’s Carr Criticizes California-Led Bid to Block Paramount-Warner Bros. Discovery Deal
Jul 16, 2026 by
CPI
EU Top Court Upholds Antitrust Powers to Seize Corporate Emails
Jul 16, 2026 by
CPI
Uber Launches $14.8 Billion Bid for Delivery Hero in Landmark Food Delivery Deal
Jul 16, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Agentic AI & Antitrust
Jul 16, 2026 by
CPI
AI Agents and Collusion: The Two Faces of Agentic AI
Jul 16, 2026 by
Giovanna Massarotto
Agentic AI’s Regulatory Conundrum
Jul 16, 2026 by
Anant Raut
Inter-AI-Agent Competition
Jul 16, 2026 by
Stefan Thomas
Navigating the Increasing Regulatory Scrutiny of AI-Pricing Tools: Competition and Other Emerging Risks
Jul 16, 2026 by
Mark Krotoski & Vinny Sidhu